Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,439,084
  • Shares Outstanding, K 208,502
  • Annual Sales, $ 3,723 M
  • Annual Income, $ 722,200 K
  • 60-Month Beta 0.85
  • Price/Sales 9.52
  • Price/Cash Flow 32.85
  • Price/Book 10.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 1.33
  • Number of Estimates 12
  • High Estimate 1.37
  • Low Estimate 1.30
  • Prior Year 1.24
  • Growth Rate Est. (year over year) +7.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
168.80 +0.34%
on 05/23/19
183.50 -7.69%
on 05/06/19
-8.35 (-4.70%)
since 04/24/19
3-Month
166.37 +1.81%
on 03/08/19
197.86 -14.39%
on 03/18/19
-3.13 (-1.81%)
since 02/22/19
52-Week
134.38 +26.05%
on 05/29/18
197.86 -14.39%
on 03/18/19
+31.81 (+23.12%)
since 05/24/18

Most Recent Stories

More News
Why Is Edwards Lifesciences (EW) Down 2.9% Since Last Earnings Report?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

EW : 169.38 (-0.35%)
HOLX vs. EW: Which Stock Is the Better Value Option?

HOLX vs. EW: Which Stock Is the Better Value Option?

HOLX : 44.69 (+0.02%)
EW : 169.38 (-0.35%)
Edwards Lifesciences' Every Heartbeat Matters Charitable Initiative On Track to Impact 1.5 Million Underserved People By 2020

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the Every Heartbeat Matters...

EW : 169.38 (-0.35%)
Bull of the Day: Penumbra (PEN)

Bull of the Day: Penumbra (PEN)

EW : 169.38 (-0.35%)
ABT : 76.98 (+1.79%)
JNJ : 138.85 (-0.67%)
PEN : 138.53 (+2.63%)
MDT : 93.03 (+2.44%)
Bull of the Day: Penumbra (PEN)

Bull of the Day: Penumbra (PEN)

EW : 169.38 (-0.35%)
ABT : 76.98 (+1.79%)
JNJ : 138.85 (-0.67%)
PEN : 138.53 (+2.63%)
MDT : 93.03 (+2.44%)
Consolidated Research: 2019 Summary Expectations for Edwards Lifesciences, Ross Stores, Thor Industries, and POSCO -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Edwards Lifesciences Corporation...

EW : 169.38 (-0.35%)
ROST : 92.78 (-1.83%)
THO : 56.72 (-0.04%)
PKX : 47.98 (+1.10%)
Favorable Study Outcomes Presented On Edwards Aortic Valves With RESILIA Tissue

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced results from the COMMENCE clinical...

EW : 169.38 (-0.35%)
Edwards Life Set to Possibly Pullback After Yesterday's Rally of 1.23%

Edwards Life (NYSE:EW) traded in a range yesterday that spanned from a low of $178.99 to a high of $181.84. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $177.89...

EW : 169.38 (-0.35%)
Utah Medical Innovations Pathways (MIP) Graduates Celebrated at State Capitol Ceremony

BioUtah applauds the 2019 graduating class of the Medical Innovations Pathways (MIP) program. On April 30, 52 high school seniors from Canyons, Davis, Granite, Jordan and Tooele school districts...

EW : 169.38 (-0.35%)
Global Heart Valve Repair and Replacement Devices Market to 2023 - Key Vendors are Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, LivaNova, & Medtronic

The "Global Heart Valve Repair and Replacement Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

EW : 169.38 (-0.35%)
BSX : 38.47 (+1.80%)
CRY : 28.33 (+1.25%)
MDT : 93.03 (+2.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade EW with:

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 173.71
1st Resistance Point 171.54
Last Price 169.38
1st Support Level 168.21
2nd Support Level 167.05

See More

52-Week High 197.86
Fibonacci 61.8% 173.61
Last Price 169.38
Fibonacci 50% 166.12
Fibonacci 38.2% 158.63
52-Week Low 134.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar